SCHEMBL4437133

SCHEMBL4437133

Cc1c(N)cc(Cl)cc1[N+](=O)[O-].Cc1c([N+](=O)[O-])cc(Cl)cc1[N+](=O)[O-]

nearest known ligand 0.46

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.46
TDP1 Q9NUW8 5/20 0.44
ALDH1A1 P00352 3/20 0.43
CYP3A4 P08684 3/20 0.43
CCR6 P51684 1/20 0.42
PDE7A Q13946 3/20 0.42
CYP1A2 P05177 1/20 0.42
RECQL P46063 1/20 0.42
MAPK1 P28482 1/20 0.40
MEN1 O00255 1/20 0.40
POLB P06746 1/20 0.40
MAPT P10636 1/20 0.40
KMT2A Q03164 1/20 0.40
ALOX15 P16050 1/20 0.40
PDE7B Q9NP56 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3611223 0.98 TSHR (0.47) TSHRTDP1ALDH1A1CYP3A4PDE7A
SCHEMBL3612247 0.88 TDP1 (0.54) TSHRTDP1ALDH1A1CYP3A4CCR6
SCHEMBL629679 0.79 TSHR (0.55) TSHRTDP1ALDH1A1CYP3A4CCR6
SCHEMBL1330407 0.79 TSHR (0.55) TSHRTDP1ALDH1A1CYP3A4CCR6
SCHEMBL3864393 0.79 TSHR (0.54) TSHRTDP1ALDH1A1CYP3A4CCR6
SCHEMBL259813 0.79 TSHR (0.60) TSHRTDP1ALDH1A1CYP3A4CYP1A2
SCHEMBL10610184 0.79 ALDH1A1 (0.47) TSHRTDP1ALDH1A1CYP3A4PDE7A
SCHEMBL8903476 0.79 ALDH1A1 (0.55) TSHRTDP1ALDH1A1CYP3A4PDE7A
SCHEMBL18829958 0.79 CYP1A2 (0.55) TSHRTDP1ALDH1A1CYP3A4CCR6
SCHEMBL938651 0.77 GPR35 (0.61) TSHRTDP1ALDH1A1CYP3A4CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2057168-A2 RAF INHIBITOR COMPOUNDS AND METHODS OF USE THEREOF Array Biopharma, Inc. (US) 2009-05-13 EP disclosed
WO-2008028141-A2 RAF INHIBITOR COMPOUNDS AND METHODS OF USE THEREOF ARRAY BIOPHARMA INC. (US) 2008-03-06 WO disclosed
US-6057349-A ALPHA.SUB.1A/1L AGONISTS USED IN THE TREATMENT OF VARIOUS DISEASE STATES SUCH AS URINARY INCONTINENCE, NASAL CONGESTION, PRIAPISM, DEPRESSION, ANXIETY, DEMENTIA, SENILITY, ALZHEIMER'S, DEFICIENCIES IN ATTENTIVENESS AND COGNITION, AND F. HOFFMAN LA ROCHE AG (CH) 2000-05-02 US disclosed